Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 16 studies | 22% ± 5% | |
CD16-positive, CD56-dim natural killer cell, human | 11 studies | 27% ± 9% | |
classical monocyte | 10 studies | 25% ± 11% | |
non-classical monocyte | 8 studies | 30% ± 12% | |
CD16-negative, CD56-bright natural killer cell, human | 7 studies | 22% ± 5% | |
plasmacytoid dendritic cell | 7 studies | 20% ± 4% | |
myeloid cell | 6 studies | 24% ± 6% | |
conventional dendritic cell | 5 studies | 30% ± 16% | |
mature NK T cell | 5 studies | 21% ± 6% | |
epithelial cell | 5 studies | 26% ± 10% | |
macrophage | 5 studies | 25% ± 5% | |
microglial cell | 5 studies | 27% ± 12% | |
monocyte | 5 studies | 19% ± 3% | |
gamma-delta T cell | 5 studies | 22% ± 4% | |
CD8-positive, alpha-beta T cell | 4 studies | 24% ± 4% | |
hematopoietic precursor cell | 4 studies | 20% ± 3% | |
regulatory T cell | 4 studies | 18% ± 3% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 20% ± 2% | |
dendritic cell | 3 studies | 37% ± 11% | |
alveolar macrophage | 3 studies | 23% ± 6% | |
effector memory CD8-positive, alpha-beta T cell, terminally differentiated | 3 studies | 21% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 7 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 4232.99 | 653 / 653 | 100% | 46.96 | 605 / 605 |
lung | 100% | 6130.30 | 578 / 578 | 99% | 45.93 | 1149 / 1155 |
kidney | 100% | 3522.36 | 89 / 89 | 99% | 33.77 | 888 / 901 |
pancreas | 96% | 1611.40 | 315 / 328 | 99% | 43.19 | 177 / 178 |
prostate | 95% | 2838.88 | 232 / 245 | 100% | 51.22 | 502 / 502 |
stomach | 81% | 2265.52 | 291 / 359 | 100% | 55.26 | 285 / 286 |
breast | 81% | 1374.13 | 370 / 459 | 99% | 37.13 | 1103 / 1118 |
skin | 75% | 1869.35 | 1361 / 1809 | 96% | 30.84 | 451 / 472 |
intestine | 61% | 4225.72 | 587 / 966 | 100% | 65.51 | 525 / 527 |
bladder | 62% | 973.90 | 13 / 21 | 98% | 44.57 | 495 / 504 |
esophagus | 48% | 974.92 | 687 / 1445 | 100% | 41.55 | 183 / 183 |
brain | 66% | 1257.91 | 1742 / 2642 | 78% | 17.79 | 549 / 705 |
adrenal gland | 100% | 2445.77 | 258 / 258 | 29% | 6.43 | 66 / 230 |
uterus | 27% | 286.57 | 46 / 170 | 97% | 47.98 | 446 / 459 |
liver | 59% | 726.09 | 134 / 226 | 60% | 10.72 | 245 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 93.22 | 29 / 29 |
peripheral blood | 100% | 22682.21 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 8905.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 58.16 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.18 | 1 / 1 |
ovary | 6% | 49.02 | 11 / 180 | 93% | 20.33 | 400 / 430 |
eye | 0% | 0 | 0 / 0 | 81% | 13.78 | 65 / 80 |
adipose | 79% | 1073.98 | 951 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 21% | 251.86 | 276 / 1335 | 0% | 0 | 0 / 0 |
heart | 8% | 70.85 | 65 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 4.80 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0007165 | Biological process | signal transduction |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0072574 | Biological process | hepatocyte proliferation |
GO_0043555 | Biological process | regulation of translation in response to stress |
GO_0006468 | Biological process | protein phosphorylation |
GO_2000491 | Biological process | positive regulation of hepatic stellate cell activation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0043027 | Molecular function | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004711 | Molecular function | ribosomal protein S6 kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RPS6KA1 |
Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) Ribosomal protein S6 kinase A1 (Ribosomal protein S6 kinase alpha-1) Ribosomal protein S6 kinase (EC 2.7.11.1) Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) |
Synonyms | RSK1 MAPKAPK1A |
Description | FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 . In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes . In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP . Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity . Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the pre-initiation complex . In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation . Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway . Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR . Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function . Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) . Mediates induction of hepatocyte prolifration by TGFA through phosphorylation of CEBPB . Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression . Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration . In response to mTORC1 activation, phosphorylates EIF4B at 'Ser-406' and 'Ser-422' which stimulates bicarbonate cotransporter SLC4A7 mRNA translation, increasing SLC4A7 protein abundance and function . .; FUNCTION: (Microbial infection) Promotes the late transcription and translation of viral lytic genes during Kaposi's sarcoma-associated herpesvirus/HHV-8 infection, when constitutively activated. . |
Accessions | ENST00000628001 ENST00000403732.2 ENST00000627677 E9PPC1 A6NND1 ENST00000628081.2 [Q15418-4] ENST00000438977.1 ENST00000531382.5 [Q15418-2] ENST00000374166.8 ENST00000529454.5 ENST00000626401 ENST00000530003.5 [Q15418-4] ENST00000629832.3 [Q15418-1] E9PPN6 E9PMM7 ENST00000526792.5 [Q15418-3] E9PGT3 ENST00000366866.8 ENST00000629099 ENST00000526040.6 ENST00000629025 ENST00000630838 Q15418 ENST00000628256.2 [Q15418-2] Q5SVM6 ENST00000625391 Q5SVM7 ENST00000631108.2 [Q15418-3] E9PAN7 ENST00000374163.5 ENST00000374168.7 [Q15418-1] ENST00000625863 ENST00000525525.5 |